ONCOLife Articles
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Clinical Trials | 13 May 2025
Bria-IMT’s Early Promise: Biomarkers Signal Path to Personalized Therapy in Breast Cancer
Clinical Trials | 2 May 2025
Leucid Bio Doses First Patient in Trial of LEU011, a CAR-T Therapy for Solid Tumors
Clinical Trials | 12 May 2025
Zongertinib Demonstrates 71% Response Rate in HER2-Mutant Lung Cancer Treatment
Clinical Trials | 2 May 2025
Elraglusib Shows Survival Benefit in First-Line Metastatic Pancreatic Cancer Trial
Clinical Trials | 7 May 2025
First-Ever KRAS G12D Inhibitor Zoldonrasib Shows 61% Response Rate in Lung Cancer
Clinical Trials | 30 April 2025
Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care'
ONCOLife | 10 May 2025
POTOMAC Trial: Durvalumab Plus BCG Boosts Outcomes in Early-Stage Bladder Cancer
Clinical Trials | 9 May 2025
New AI-Powered Urine Test Detects Prostate Cancer with Higher Precision than PSA
ONCOLife
2 May 2025
Pembrolizumab Improves Event-Free Survival in Resectable Head and Neck Cancer
Clinical Trials
28 April 2025
Bayer Launches First-in-Human Trial of Targeted Alpha Therapy for Advanced Liver Cancer
Clinical Trials
30 April 2025
Sasanlimab Plus BCG Shows Significant Survival Benefit for NMI Bladder Cancer
Clinical Trials
26 April 2025
Enhertu Redefines First-Line Treatment for HER2+ Metastatic Breast Cancer
Clinical Trials
23 April 2025
Trodelvy and Keytruda Combination Marks Breakthrough in mTN-Breast Cancer
Clinical Trials
22 April 2025
Ivonescimab Shows Significant Improvement in First-Line Treatment of NSCLC
Clinical Trials
23 April 2025
Nimbus Launches First Human Trial of Promising WRN Inhibitor for MSI-H Cancers
Clinical Trials
25 April 2025
SkinJect Patch Shows Early Success in Phase 2 Study for Basal Cell Carcinoma
Clinical Trials
21 April 2025
First Patient Dosed in Phase 2 Trial of MB-105, CD5 CAR-T Therapy for T-Cell Lymphoma
Clinical Trials
22 April 2025
Durvalumab Shows Significant Survival Benefit in Gastric and GEJ Cancer Treatment
Clinical Trials
7 March 2025
Nivolumab Plus Chemotherapy Demonstrates Survival Benefit in Resectable NSCLC
Clinical Trials
22 February 2025
How SkinJect's Microneedle Technology Could Transform the Treatment of Skin Cancer
ONCOLife
5 March 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
